Serum procalcitonin levels in bacterial and abacterial meningitis

Critical Care Medicine

Volumn 28, Issue 6, 2000, Pages 1828-1832

  Schwarz, Stefan ^a   Bertram, Markus ^a   Schwab, Stefan ^a   Andrassy, Konrad ^a   Hacke, Werner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

C reactive protein; Cerebrospinal fluid; Lactate; Meningitis; Procalcitonin; Sepsis

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; LACTIC ACID; M PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SEPSIS;

EID: 0033932745     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200006000-00024     Document Type: Article

References (36)

1. 1. Becker K, Nylen E, Cohen R, et al: Calcitonin: Structure, molecular biology, and actions. In: Principles of Bone Biology. Bilenzikian J, Raisz L, Rodan G (Eds). New York, Academic Press, 1996, pp 471-494
2. 2. Assicot M, Gendrel D, Carsin H, et al: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-518
3. 3. Smith MD, Suputtamongkol Y, Chaowagul W, et al: Elevated serum procalcitonin levels in patients with melioidosis. Clin Infect Dis 1995; 20:641-645
4. 4. Gendrel D, Assicot M, Raymond J, et al: Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996; 128: 570-573
5. 5. Al-Nawas B, Shah PM: Procalcitonin in patients with and without immunosuppression and sepsis. Infection 1996; 24:434-436
6. 6. Chiesa C, Panero A, Rossi N, et al: Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998; 26:664-672
7. 7. Monneret G, Labaune JM, Isaac C, et al: Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr 1997; 86: 209-212
8. 8. Eberhard OK, Haubitz M, Brunkhorst FM, et al: Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40:1250-1256
9. 9. Rau B, Steinbach G, Gansauge F, et al: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41:832-840
10. 10. de-Werra I, Jaccard C, Corradin SB, et al: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25:607-613
11. 11. Dandona P, Nix D, Wilson MF, et al: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79:1605-1608
12. 12. Nylen ES, Whang KT, Snider R Jr, et al: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26:1001-1006
13. 13. Lindquist L, Linné T, Hansson L, et al: Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: A study of 710 patients with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis 1988; 7:374-380
14. 14. Roos K, Scheld W: The management of fulminant meningitis in the intensive care unit. Crit Care Med 1988; 4:375-392
15. 15. Roos K, Tunkel A, Scheld W: Acute bacterial meningitis in children and adults. In: Infections of the Central Nervous System. Scheld W, Whitley R, Durack D (Eds). New York, Raven Press, 1991, pp 335-409
16. 16. Sigurdardottir B, Björnsson O, Jonsdottir K, et al: Acute bacterial meningitis in adults. Arch Intern Med 1997; 157:425-430
17. 17. Durand M, Calderwood S, Weber D, et al: Acute bacterial meningitis in adults. N Engl J Med 1993; 328:21-28
18. 18. Gendrel D, Raymond J, Assicot M, et al: Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24:1240-1242
19. 19. The ACCP/SCCM American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
20. 20. Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1975; i:480-484
21. 21. Hagberg L, Dotevall L, Norkrans G, et al: Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis 1993; 168:1285-1288
22. 22. Dulkerian SJ, Kilpatrick L, Costarino A Jr, et al: Cytokine elevations in infants with bacterial and aseptic meningitis. J Pediatr 1995; 126:872-876
23. 23. Matsuzono Y, Narita M, Akutsu Y, et al: Interleukin-6 in cerebrospinal fluid of patients with central nervous system infections. Acta Paediatr 1995; 84:879-883
24. 24. Hashim IA, Walsh A, Hart CA, et al: Cerebrospinal fluid interleukin-6 and its diagnostic value in the investigation of meningitis. Ann Clin Biochem 1995; 32:289-296
25. 25. Torre D, Zeroli C, Ferraro G, et al: Cerebrospinal fluid levels of IL-6 in patients with acute infections of the central nervous system. Scand J Infect Dis 1992; 24:787-791
26. 26. Lopez-Cortes LF, Cruz-Ruiz M, Gomez-Mateos J, et al: Interleukin 6 in cerebrospinal fluid of patients with meningitis is not a useful diagnostic marker in the differential diagnosis of meningitis. Ann Clin Biochem 1997; 34:165-169
27. 27. Chavanet P, Bonnette B, Guiguet M, et al: High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitis. J infect Dis 1992; 166:428-431
28. 28. Seki T, Joh K, Oh-ishi T: Augmented production of interleukin-8 in cerebrospinal fluid in bacterial meningitis. Immunology 1993; 80: 333-335
29. 29. Ossege LM, Sindern E, Voss B, et al: Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in cerebrospinal fluid cells in meningitis. J Neurol Sci 1996; 144:1-13
30. 30. Leist TP, Frei K, Kam-Hansen S, et al: Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients. J Exp Med 1988; 167:1743-1748
31. 31. Ichiyama T, Hayashi T, Furukawa S: Cerebrospinal fluid concentrations of soluble tumor necrosis factor receptor in bacterial and aseptic meningitis. Neurology 1996; 46: 837-838
32. 32. Stahel P, Nadal D, Pfister H, et al: Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis. Lancet 1997; 349:1886-1887
33. 33. Meisner M, Tschaikowsky K, Schnabel S, et al: Procalcitonin-influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur J Clin Chem Clin Biochem 1997; 35:597-601
34. 34. Karzai W, Oberhoffer M, Meier-Hellmann A, et al: Procalcitonin-a new indicator of the systemic response to severe infections. Infection 1997; 25:329-334
35. 35. Gerard Y, Hober D, Assicot M, et al: Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1. J Infect 1997; 35:41-46
36. 36. Huber W, Schweigart U, Bottermann P: Failure of PCT to indicate severe fungal infection in two immunodeficient patients. Infection 1997; 25:377-378